To explore the need for self-monitoring and self-care education in heart failure patients with diabetes (HF-DM patients) by describing cognitive and affective factors to provide guidance in developing effective selfmanagement education.
HF medication-taking behaviors. The HF-DM patients consumed significantly lower total sugar than HF patients but clinically higher levels of sodium.
Conclusions
Diabetes educators need to be aware of potential conflicts of treatment regimens to manage 2 chronic diseases. Special and integrated diabetes self-management education programs that incorporate principles of HF self-management should be developed to improve selfmanagement behavior in HF-DM patients.
A n estimated 2.5 million Americans have both heart failure (HF) and diabetes mellitus (DM), which represents 30% to 47% of the total HF patients. 1, 2 The prevalence of HF-DM, unfortunately, is projected to increase over the next decade for several reasons. [3] [4] [5] A study that reviewed 14 randomized clinical trials between 1989 and 1999 (n = 34 633) found a dramatically growing prevalence of DM in HF patients. Whereas a 54% increase of diabetes prevalence is found in the general population, a 360% increase was reported in persons with HF. 3 As consequence, HF patients become a very high risk group for developing DM concurrently.
The increasing prevalence of diabetes, especially type 2 diabetes (T2DM), will also cause a surge in the HF-DM population. In diabetes care, poor glycemic control is a big concern, and patients with uncontrolled diabetes are at 2.5 times higher risk to develop HF. 6, 7 In 2009, about 8% of Americans had diabetes, and it is estimated that the prevalence will double by 2050. 8 With every 1% increase in A1C, the risk of development of HF is increased by 17% to 32%. 9, 10 It is well known that the obesity epidemic increases vulnerability to cardiovascular diseases and T2DM. Twothirds of Americans are overweight or obese, 11 and strong relationships between obesity, high blood pressure, dyslipidemia, and T2DM have been identified. 7, [12] [13] [14] For instance, each 1% of weight gain corresponds to an increase of 1 mm Hg systolic and 2 mm Hg diastolic blood pressure, and every 2.2-lb (1-kg) gain in body weight results in a 1% increase in low-density lipoprotein cholesterol. 15 The aging US population contributes to an increasing prevalence of HF, DM, and HF-DM since age is a significant risk factor for developing HF and DM. In the United States, adults aged 65 and over are the fastest growing age group. The first "baby boomers" (adults born between 1946 and 1964) turn 65 in 2011. By 2030, 18% of Americans will be 65 years and over, and this percentage will continue to grow. 14 Without a doubt, patients with concomitant HF-DM are a growing population in the United States.
When patients have HF and DM concurrently, selfcare demands mount considerably. Their treatment regimens are frequently added to, changed, or adjusted, requiring these patients to make new accommodations to optimally manage their symptoms and to reduce potential for future health problems. Clearly, patients' knowledge, confidence, skills, and self-management behaviors are key to achieving new treatment goals.
Treatment goals for HF patients are to control hypertension and dyslipidemia, avoid fluid retention (ie, <2 lb body weight changes in a day or 5 lb in a week), and monitor and manage symptoms (ie, dyspnea, coughing, fatigue, dizziness). 16 Treatment goals for persons with diabetes are to control blood glucose (A1C <7.0%), blood pressure (<130/80 mm Hg), and cholesterol (lipid cholesterol <100 mg/dL) to prevent acute or chronic diabetes complications. 7 For HF-DM patients, a combined treatment regimen with many lifestyle changes and self-monitoring is required to control these 2 separate diseases concomitantly. Treatment regimens for persons with HF, DM, and HF-DM share similarities; however, the individual regimens differ. For instance, both DM patients and HF-DM patients are asked to control glucose, but optimal glucose levels are different. 17 Studies found that moderate glycemic control (an A1C of 7.1%-7.8%) is more beneficial than tight glycemic control (A1C <7%) for HF-DM patients to reduce mortality rate. 6, 18 Another issue unique to persons with HF-DM is the self-management of symptoms requiring the differentiation of causes. Although feeling tired or weak is common in HF patients due to inadequate perfusion, hyperglycemia may be a cause in persons with HF-DM. 6 Similarly, dizziness can be a symptom from hypoglycemia or may be a side effect of β-blockers or other medications. Without an accurate understanding of overlapping symptoms and appropriate self-management, patients may lack the confidence and skills to successfully manage symptoms or may blame their symptoms on side effects of treatment regimens. This may result in nonadherence, hospitalization, worsening health, and the patient feeling overwhelmed and depressed about managing these 2 diseases.
Dietary recommendations also differ between persons with HF, DM, and combined HF-DM. Although calorieand carbohydrate-restricted diets to control blood glucose are critical for persons with DM, a sodium-restricted diet is necessary for persons with HF to limit fluid accumulation. 7, 19 For HF-DM patients, a sodium-restricted diet would be strictly prescribed because of a possible relationship between sodium intake, hypertension, and insulin resistance. 12, 20, 21 Fluid restriction may also be recommended for some persons with HF, whereas thirst from increased glucose levels may trigger fluid intake in those with DM. In both groups, recommendations to limit dietary cholesterol and increase consumption of foods rich in ω3 fatty acids are recommended to limit further cardiovascular complications. 7, 19 Consequently, this area of diet self-management can be very difficult for those with HF-DM, and considerable and continued education with strong emotional support is necessary for these patients, who have fewer food choices.
Researchers recently have focused attention to the reciprocal relationship between HF and DM. 9, 22 In the failing heart, there are increased demands for oxygen and energy, which is further complicated by a loss in the ability to use glucose appropriately due to insulin resistance. To improve these conditions, many medications (eg, diuretics, ω-receptor blockers, angiotensin-converting enzyme [ACE] inhibitors, calcium channel brokers, oral hypoglycemic agents, insulin) are prescribed. However, these medications often generate other health problems related to side effects. For instance, thiazolidinediones, which increase insulin sensitivity, especially in adipose tissue, are contradicted for HF patients due to the propensity for fluid retention. 20, 23 The biguanide metformin is a very effective and economical medication to control diabetes and to reduce cardiovascular-related complications in patients with DM. However, it has a "black-box" warning for HF-DM patients. 6, 24 Diuretics, particularly thiazide diuretics, decrease glucose tolerance. 25 Longterm use of β-adrenergic blockers, high doses of calcium channel blockers, and use of multiple agents generate increased risk for developing DM. 25, 26 Given these formidable challenges for HF-DM patients, evidence-based self-management support is vital to provide opportunities for patients to become active self-managers to control their chronic disorders. 6, 22 The factors associated with good self-management outcomes include knowledge, 22, 27 self-efficacy, 28, 29 and provider support. 29 Depressive symptoms and lack of motivation may be also related to reduced or ineffective self-management behaviors for both HF and DM. 30, 31 Very limited information, however, is available to design effective self-management education program for HF-DM patients.
The purpose of this study was to explore the need for self-monitoring and self-care education for HF-DM patients by describing cognitive and affective factors that are theoretically related to self-management. Specific aims were to compare difference between persons with HF alone and with DM on (1) sociodemographic and clinical characteristics including health status, comorbid conditions, and recent health resource use that have been linked to self-management behaviors; (2) measures of cognitive and affective factors describing self-management behavior (knowledge, relationships with health care provider, depression, self-efficacy); and (3) current selfmanagement behaviors.
Methods

Study Design
A cross-sectional, correlational design was used to analyze baseline participant data from a study testing a 12-week family-focused intervention to improve dietary and medication-taking self-management behaviors in persons with HF.
Sample and Setting
Between 2005 and 2008, 117 NYHA class II and III patients with HF were recruited from the metropolitan Atlanta area. Inclusion criteria for participants were the ability to read, write, and speak English; telephone access; medication regimens that included ACE inhibitors or angiotensin receptor blockers and diuretics or documented contraindications to these; a low-sodium diet; ambulatory status; and adequate renal function documented by a glomerular filtration rate greater than 30. Prior to the study, an approval from the institutional review board of Emory University was obtained, and all participants gave written informed consent.
Measures and Variables
Variables were derived from an integrated theoretical framework developed to guide HF self-care studies. 32 The framework articulates the relationships among factors considered antecedent to performing self-care (which include certain demographic factors and comorbidities, physical function, psychological factors, social support such as relationship with health care provider, selfefficacy for medication taking, and low-sodium diet) and behavioral outcomes (medications, dietary habits). These variables were assessed in the study.
Demographics and comorbidities were assessed with items regarding age, gender, ethnicity, marital status, education, living arrangement, perceived health, NYHA classification, health insurance status, smoking and alcohol use, and current medications. The Charlson Comorbidity Index was used to assess comorbid conditions. This scale was originally developed to quantify risk of death from comorbid disease using the number of comorbidity and weights. The possible total scores range from 0 to 37. 33 Physical function was assessed with the 6-minute walk test. Distance walked in 6 minutes correlates moderately with symptom score and NYHA class, and it independently and strongly predicts 1-year mortality and hospitalization in patients with advanced HF. 34 Participants were asked to walk as far as possible along a level hallway in the Clinical Research Center marked off in 100-ft increments for 6 minutes. Then, the distance walked in feet and meters was calculated with the monitoring of heart rate, blood pressure and respiratory rate, and perceived exertion. 35, 36 Health care resource use was assessed with the Health Resources Utilization Questionnaire (HRUQ) with items regarding numbers of hospitalizations for HF and non-HF causes and numbers of emergency department visits in the past 4 months.
Previous HF education was measured with 8 yes/no questions. Participants were asked whether they had received prior HF education about fluid restriction, daily weight, symptom management, medication, anxiety, diet, alcohol use, and smoking cessation.
Depressive symptoms were measured using the Beck Depression Inventory II (BDI-II), which consists of 21 items rated on a 0-3 scale that ask about participants' feelings in the past 2 weeks. 37 Higher score indicates greater depressive symptoms. This self-reported scale has been widely used in HF patients, and the reported Cronbach α in this population was .86 to .89. 38 Patients' perceived support from a health care provider with an HF specialty was measured with Health Care Climate Questionnaire (HCCQ) consisting of 15 items. A higher score indicates a greater perception of supportive relationships with health care providers. The Cronbach α was previously reported as .95 and was .91 in this study. 39 Knowledge about HF was assessed with a 27-item scale using multiple-choice questions. Knowledge about HF regarding pathophysiological characteristics, nutrition, behavior, symptom, and medication was assessed. The instrument is scored according to the percentage of questions answered correctly. This scale demonstrated good reliability (α = .84) and validity. 22 Medication-taking self-efficacy and low-sodium diet self-efficacy were measured by 2 self-efficacy scales derived from the perceived competence scales developed by Williams and colleagues. 29 Each scale consists of 4 items rated on 1-7 Likert scale (1 = strongly disagree to 7 = strongly agree) with which the participants indicated their degree of confidence in their ability to follow a low-sodium diet and manage their medications. Cronbach α was .95 and .93 for diet and medication scales, respectively.
Medication-taking behavior was measured by subjective and objective scales. An 8-item Morisky scale was used to assess items related to heart failure medications behavior. The first 7 items use dichotomous responses of yes = 1 or no = 0; the last item uses a 5-point Likert scale (1 = never to 5 = all the time). The possible range of scores for this instrument is 1 to 12. The Medication Event Monitoring System (MEMS) is an electronic monitoring device that records cap opening. Using these records, researchers can obtain days of medication taking and numbers of medications taken. For this study, the percentage of days of ACE inhibitor use and diuretic adherence for a 2-week baseline period were measured.
Dietary intake was assessed with a 3-day food record maintained by the participants, who recorded all meals and snacks including beverages over 3 days, preparation techniques, and details of condiments. The records were reviewed by the study research dietician, blinded to group assignment, who prompted the participant for greater details on food preparation, portions, and discretionary salt use. The diet record information was analyzed with a computerized food composition software program (Nutritionist V®, First Databank, San Bruno, CA) for macronutrients and micronutrients consumed and averaged for the 3 days.
Data Analysis
The data were analyzed using SPSS for Windows version 18.0 (SPSS Inc, Chicago, IL). Prior to analysis, all the data were examined for the accuracy of data entry, missing values, and missing patterns. Of the 117 participants, one participant who self-reported having diabetes but was missing data for oral hypoglycemic agents and insulin was excluded. Thus, 116 participants remained for the final data analysis. To answer specific aim 1, descriptive statistics and/or chi-square tests were used. To answer specific aims 2 and 3, a series of t tests and Mann-Whitney tests were used based on data distributions.
Results
Of the total sample, a majority of participants were male (n = 73, 62.9%) and African American (n = 67, 57.8%). The mean age was 55.8 ± 10.5 years (median age, 56.0 years; range, 28-78 years), and 40.5% (n = 47) of the participants had high school or lower level of education. The majority of the participants were diagnosed with HF for at least 5 years, but about 30% had learned of their HF in the past 2 years. Approximately, 40% (n = 46) of the participants had HF as well as DM. The average number of years diagnosed with diabetes was 11.55 (SD = 8.86; median, 8.50 years; range, 2-38 years).
Nearly three-fourths of participants (n = 84, 72.4%) had NYHA classification II. Although most of the participants were nonsmokers (ie, never smoker, 51.72%, n = 60; former smoker, 36.21%, n = 42), former and current smokers had a long smoking history. For the 55 smokers (current, recent, former), the average number of packs per year was 36.25 (SD 29.19) , median 30 packs per year, range from less than 1 pack per year to 141 packs per year. No significant difference on the pack year in HF patients with and without DM was identified. Interestingly, alcohol consumption was significantly lower in HF-DM patients (9 HF subjects drank 2 drinks per week compared with 0 HF-DM subjects). About half of participants in both groups reported that their perceived health conditions were fair or poor (Table 1) .
Differences in Health-Related Conditions
Although there was no significant difference on the NYHA classification between patients with and without DM, HF-DM patients were older and heavier, had more comorbidities, and took more daily medications than HF patients without DM. HF-DM patients reported more frequent hospitalizations (range, HF 0-4, HF-DM 0-15) and longer lengths of stay (4.86 ± 12.31 vs 1.82 ± 3.80) for HF in the prior 4 months, but there were no statistically significant differences between groups. With regard to the level of physical function, the majority of participants were able to perform the 6-minute walk test without difficulty or adverse symptoms; although HF-DM patients walked less distance at 3 minutes and 6 minutes, this difference was not statistically significant.
HF-DM patients reported significantly higher rates of hypertension and sleep apnea, and a larger percentage of HF-DM patients had a history of depression than did the patients with HF alone. Of HF-DM patients, about onehalf took daily insulin and one-third took oral hypoglycemic agents to control blood glucose, with few taking both oral hypoglycemic agent and insulin ( Table 2) . Table 3 shows the mean differences on the cognitive and affective factors describing self-management behavior between HF patients with and without DM. There were no significant differences between the groups on the perceived support from health care providers with regard to management of HF conditions, level of depressive symptoms, diet self-efficacy, or medication selfefficacy. Overall, patients reported slight to moderate levels of the support from health care providers to manage their HF conditions.
Cognitive and Affective Factors Describing Self-Management Behavior
Self-Management Behavior
To address specific aim 3, HF-DM participants were compared with HF alone on specific self-care behaviors of medication taking and dietary habits ( Table 4 ). The participants reported good medication-taking adherence on the self-reported and electronic measures. Total calorie consumption was relatively low considering patients' body mass index and national nutrition guidelines. 40 HF-DM patients consumed higher amounts of saturated fat, protein, and dietary fibers and lower amounts of carbohydrate than did HF patients without DM, although there were no statistically significant differences on these dietary components. None of patient groups achieved the recommended nutrition goals. HF-DM patients had significantly lower sugar intake than HF patients. In a separate detailed analysis reported elsewhere, this lower sugar intake in HF-DM patients was found in men and not women. 41 Of importance clinically, HF-DM patients ingested higher levels of sodium, a mean of greater than 250 mg/d more than those without DM (Table 4 ).
Discussion
The demands of self-care are synergistically escalated when patients have HF and DM simultaneously. The required self-care regimens often overlap and are complex because an exacerbation of one condition may trigger an exacerbation of the other condition. Without support to improve their knowledge, skills, and confidence in managing these demanding comorbidities, patients may experience greater symptoms and are vulnerable to feeling overwhelmed and depressed. 42 In the current study, HF-DM patients reported more comorbidities and a greater number of medications than those who had HF and no DM. HF-DM patients also reported a greater history of depression and greater incidence of sleep apnea, although BDI-II showed no significant difference in depressive symptoms. Since psychological distress (eg, depressive symptoms) is significantly related to medication adherence and disease progression in patients with chronic disorders, 30, 31 patients' depressive symptoms and coping mechanisms should be carefully evaluated. Then appropriate support programs to treat depressive symptoms as well as develop problem-solving and coping skills could be offered to promote effective healthy behavior in patients with HF and HF-DM. 43 With regard to education in managing HF symptoms, the majority of patients reported that they had received previous education on fluid retention, medication, and symptom management. Their self-efficacy on managing medications and following a low-sodium diet was very high as well. However, these findings should be carefully interpreted before planning and implementing education for HF-DM patients since the reported confidence may be "wishful thinking" rather than actual confidence: patients may not realize the actual difficulties and barriers until they encounter a situation. 44 Nurse educators need to be aware of this gap and assess patients' current knowledge, confidence, skills, and behaviors related to the requested treatment regimens for both conditions. Based on this assessment, strategies to solve problems and barriers should be included in self-management education. 43 Although the diabetic diet is important for HF-DM patients to control blood glucose, only 70% of the HF-DM patients reported that they were on a diabetic diet. Accordingly, many potential educational areas in relation to dietary habits were identified. When patients have HF, DM, or both, they have a higher likelihood of experiencing a cardiovascular event (eg, stroke or cardiac arrest) as a complication. Thus, low-fat and lowcholesterol diets are strongly recommended to reduce these risks. 7 Notable is the fact that both groups reported diets high in saturated fat. Thus, reduced consumption of saturated fat and cholesterol should be a part of HF-DM patient education.
Reduced sodium consumption should be strongly emphasized in both groups. In the current study, our patients consumed excessive amounts of sodium in their reported diets. In particular, HF-DM patients consumed almost double the amount of recommended sodium. The HF-DM patients had a significantly lower sugar intake than HF patients, though. This may be related to the availability of feedback measures to assess sodium and glucose levels. Although patients can get more immediate feedback using simple home glucose testing, they meet difficulties in accurately measuring sodium intake. This finding may be related to previous diabetes selfmanagement education, which emphasized carbohydrate counting. Further study may yield important information related to how patients learn about dietary regimens and how they make food selection decisions.
Interestingly, the HF-DM patients consumed less alcohol than the HF patients in the current study. Again, this may be related to previous diabetes self-management education. Medical Nutritional Therapy (MNT), which is a main component of Standards of Medical Care in Diabetes, emphasizes limiting alcohol intake because of carbohydrate content (ie, ≤1 drink per day for women and ≤2 drinks per day for men). 7 This information is frequently addressed in diabetes education materials. Thus, HF-DM patients may be exposed on the MNT guidelines, and their knowledge about alcohol may, as a consequence, influence actual drinking behavior. These findings should be revisited to explore the powers of specific and achievable objectives and to develop standardized dietary guidelines for HF-DM patients. 45 Despite the significance of this study, there are several limitations. First, the study only examined a crosssectional description of variables related to self-care, which may not reflect patterns or relationships over time. Second, the study did not assess either previous diabetes self-management education history or current diabetes self-management behaviors such as glucose monitoring and current glycemic control status. Also, we obtained limited information about which chronic condition developed first. Therefore, it is difficult to explain reasons for dietary differences in patients with HF and HF-DM. Third, we monitored 2 heart failure drugs, not diabetes medications, using electronic measurements regardless of patients' current chronic conditions. Not surprisingly, HF-DM patients took multiple medications to control their health conditions, and route and time of administration of each medication were often different (eg, before or after meal, injection or oral medication). Thus, it is possible that HF-DM patients may adhere well for one oral medication but not for other medications such as insulin. Also, they schedule medications based on the knowledge of a single drug rather than understanding of drug interactions. Finally, increasing family-wise error rate may be a concern in the findings since we analyzed the data using multiple t tests and Mann-Whitney tests. However, this study is an initial step to describe the relative differences between HF and HF-DM patients in order to raise diabetes educators' awareness of potential conflicts of treatment regimens and provide a basis for the development of education protocols for this specific population. Thus, this concern should be minimized.
Implications for Practice
Study findings indicated a need to develop and test a comprehensive and integrated education program for HF-DM patients who need to manage 2 chronic conditions. Single-disease-specific education may not provide effective information to confront the self-care needs of patients with multiple chronic disorders. Rather, they may receive more benefit from a multidisease perspective with an individualized and comprehensive approach. This should include when and whom to contact when HF or DM symptoms flare up, how to effectively communicate with multiple health care providers, and how to appropriately use available community and financial resources. 42 Partnership between proactive patients and a well-prepared health care team is essential to achieve optimal care for HF-DM patients, who require frequent regimen adjustments. An opportunity to develop a systematic and standardized protocol for HF-DM patients should be explored with collaboration between the HF team and certified diabetes educators.
